Gastroenteropancreatic Neuroendocrine Tumors

• FDA approval · 2023-02-21
  FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)

  FDA approved a supplemental application to Heritage Pharmaceuticals (Avet) for octreotide acetate, a generic product, under an ANDA.

• FDA approval · 2022-02-09
  FDA Approved: OCTREOSCAN — Supplemental Application (Curium US LLC)

  FDA documents a supplemental approval application for OCTREOSCAN (Indium-111 pentetreotide) submitted by Curium US LLC.

• FDA approval · 2020-05-28
  FDA Approved: LUTATHERA — Supplemental Application (Advanced Accelerator Applications USA, Inc)

  FDA approved a supplemental application for Lutathera (lutetium-177 dotatate) submitted by Advanced Accelerator Applications USA, Inc.

• FDA approval · 2018-02-22
  FDA Approved: SOMATULINE DEPOT — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)

  The FDA approved a supplemental application for Somatuline Depot (lanreotide acetate) submitted by Ipsen Biopharmaceuticals, Inc.

• FDA approval · 2017-07-10
  FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Sagent Pharmaceuticals)

  FDA approves a supplemental application for Octreotide Acetate submitted by Sagent Pharmaceuticals.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2014-12-16
  FDA Approved: SOMATULINE DEPOT — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)

  The FDA approved a supplemental application for Somatuline Depot (lanreotide acetate) from Ipsen Biopharmaceuticals, Inc., updating regulato…

• FDA approval · 2014-10-28
  FDA Approved: SOMATULINE DEPOT — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)

  The FDA approved a supplemental application for Somatuline Depot (lanreotide acetate) from Ipsen Biopharmaceuticals, Inc., expanding its app…

• FDA approval · 2014-01-30
  FDA Approved: SANDOSTATIN LAR DEPOT — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approved a supplemental application for Sandostatin LAR Depot (octreotide acetate) submitted by Novartis Pharmaceuticals Corporation. Th…

• FDA approval · 2011-03-04
  FDA Approved: SOMATULINE DEPOT — Supplemental Application (Ipsen Biopharmaceuticals, Inc.)

  FDA approved a supplemental application for Somatuline Depot (lanreotide acetate) submitted by Ipsen Biopharmaceuticals, Inc.

• FDA approval · 2007-08-30
  FDA Approved: SOMATULINE DEPOT — Original Application (Ipsen Biopharmaceuticals, Inc.)

  The FDA approved Somatuline Depot (lanreotide acetate) under the Original Application for Ipsen Biopharmaceuticals.